Genital Diseases, Female  >>  apremilast  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
apremilast / Generic mfg.
NCT00814632: CC-10004 For The Treatment Of Vulvodynia

Completed
2
10
US
CC-10004, Study Drug
Kenneth Peters, MD, Celgene Corporation
Vulvodynia
02/11
02/11

Download Options